D
Cartesian Therapeutics, Inc. RNAC
$10.78 -$0.47-4.18% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 15.89M -17.71M -10.25M -24.18M 13.84M
Total Depreciation and Amortization 589.00K 1.16M 486.00K 286.00K 196.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -32.49M 528.00K -4.08M 11.78M 3.60M
Change in Net Operating Assets -1.51M -7.08M 6.85M 25.81M -32.08M
Cash from Operations -17.52M -23.11M -7.00M 13.69M -14.45M
Capital Expenditure -2.60M -1.08M -705.00K -6.20M -1.59M
Sale of Property, Plant, and Equipment -- -- 351.00K -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -2.60M -1.08M -354.00K -6.20M -1.59M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 85.00K 183.00K 849.00K 124.49M 120.00K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- 0.00 0.00 0.00
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -25.00K -8.21M -66.00K -- --
Cash from Financing 60.00K -8.03M 783.00K 124.49M 120.00K
Foreign Exchange rate Adjustments 12.00K 32.00K -15.00K -15.00K 14.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -20.04M -32.18M -6.59M 131.97M -15.90M